Literature DB >> 17949375

Misoprostol: first-line therapy for incomplete miscarriage in the developing world.

K Gemzell-Danielsson1, C Fiala, A Weeks.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17949375     DOI: 10.1111/j.1471-0528.2007.01491.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


× No keyword cloud information.
  4 in total

1.  Barriers and facilitators in the provision of post-abortion care at district level in central Uganda - a qualitative study focusing on task sharing between physicians and midwives.

Authors:  Mandira Paul; Kristina Gemzell-Danielsson; Charles Kiggundu; Rebecka Namugenyi; Marie Klingberg-Allvin
Journal:  BMC Health Serv Res       Date:  2014-01-21       Impact factor: 2.655

2.  Simplified follow-up after medical abortion using a low-sensitivity urinary pregnancy test and a pictorial instruction sheet in Rajasthan, India--study protocol and intervention adaptation of a randomised control trial.

Authors:  Mandira Paul; Kirti Iyengar; Sharad Iyengar; Kristina Gemzell-Danielsson; Birgitta Essén; Marie Klingberg-Allvin
Journal:  BMC Womens Health       Date:  2014-08-15       Impact factor: 2.809

3.  Assessing post-abortion care in health facilities in Afghanistan: a cross-sectional study.

Authors:  Nasratullah Ansari; Partamin Zainullah; Young Mi Kim; Hannah Tappis; Adrienne Kols; Sheena Currie; Jaime Haver; Jos van Roosmalen; Jacqueline E W Broerse; Jelle Stekelenburg
Journal:  BMC Pregnancy Childbirth       Date:  2015-02-03       Impact factor: 3.007

4.  Post-abortion care with misoprostol - equally effective, safe and accepted when administered by midwives compared to physicians: a randomised controlled equivalence trial in a low-resource setting in Kenya.

Authors:  Marlene Makenzius; Monica Oguttu; Marie Klingberg-Allvin; Kristina Gemzell-Danielsson; Theresa M A Odero; Elisabeth Faxelid
Journal:  BMJ Open       Date:  2017-10-10       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.